Trexquant Investment LP Karyopharm Therapeutics Inc. Transaction History

Trexquant Investment LP

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$4.08 - $5.82 $95,451 - $136,158	23,395 Added 24.34%	119,526 $653,000
Q2 2022 Aug 11, 2022	BUY	$4.15 - $8.37 $278,145 - $560,982	67,023 Added 230.26%	96,131 $434,000
Q1 2022 May 13, 2022	SELL	$5.91 - $14.38 $1.13 Million - $2.76 Million	-191,767 Reduced 86.82%	29,108 $215,000
Q4 2021 Feb 14, 2022	BUY	$5.21 - $8.61 $962,151 - $1.59 Million	184,674 Added 510.14%	220,875 $1.42 Million
Q3 2021 Nov 12, 2021	BUY	$4.45 - $10.63 $51,882 - $123,935	11,659 Added 47.51%	36,201 $211,000
Q2 2021 Aug 12, 2021	SELL	$8.11 - $11.11 $77,928 - $106,755	-9,609 Reduced 28.14%	24,542 $253,000
Q1 2021 May 13, 2021	SELL	$9.85 - $17.69 $22,152 - $39,784	-2,249 Reduced 6.18%	34,151 $359,000
Q4 2020 Feb 11, 2021	BUY	$14.15 - $17.19 $515,060 - $625,716	36,400 New	36,400 $563,000
Q3 2020 Nov 06, 2020	SELL	$14.14 - $19.71 $602,915 - $840,414	-42,639 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$16.6 - $25.25 $707,807 - $1.08 Million	42,639 New	42,639 $808,000
Q3 2019 Nov 08, 2019	SELL	$5.66 - $11.85 $95,693 - $200,347	-16,907 Closed	0 $0
Q2 2019 Aug 09, 2019	SELL	$4.32 - $6.43 $34,905 - $51,954	-8,080 Reduced 32.34%	16,907 $101,000
Q1 2019 May 13, 2019	BUY	$4.12 - $10.25 $102,946 - $256,116	24,987 New	24,987 $146,000
Q3 2018 Nov 09, 2018	SELL	$17.03 - $21.18 $199,983 - $248,716	-11,743 Closed	0 $0
Q2 2018 Aug 07, 2018	SELL	$12.0 - $19.88 $231,288 - $383,167	-19,274 Reduced 62.14%	11,743 $200,000
Q1 2018 May 03, 2018	BUY	$9.92 - $17.25 $307,688 - $535,043	31,017 New	31,017 $416,000

56.5M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $49.5M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.